Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles.

CD14 CD162 (PSGL-1) CD81 (tetraspanin) calibrated flow virometry flow cytometry human immunodeficiency virus (HIV) integrin α4β7 molecules of equivalent soluble fluorophore (MESF) virion-incorporated proteins

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
12 11 2020
Historique:
received: 12 10 2020
revised: 04 11 2020
accepted: 09 11 2020
entrez: 17 11 2020
pubmed: 18 11 2020
medline: 4 3 2021
Statut: epublish

Résumé

The HIV-1 glycoprotein spike (gp120) is typically the first viral antigen that cells encounter before initiating immune responses, and is often the sole target in vaccine designs. Thus, characterizing the presence of cellular antigens on the surfaces of HIV particles may help identify new antiviral targets or impact targeting of gp120. Despite the importance of characterizing proteins on the virion surface, current techniques available for this purpose do not support high-throughput analysis of viruses, and typically only offer a semi-quantitative assessment of virus-associated proteins. Traditional bulk techniques often assess averages of viral preparations, which may mask subtle but important differences in viral subsets. On the other hand, microscopy techniques, which provide detail on individual virions, are difficult to use in a high-throughput manner and have low levels of sensitivity for antigen detection. Flow cytometry is a technique that traditionally has been used for rapid, high-sensitivity characterization of single cells, with limited use in detecting viruses, since the small size of viral particles hinders their detection. Herein, we report the detection and surface antigen characterization of HIV-1 pseudovirus particles by light scattering and fluorescence with flow cytometry, termed flow virometry for its specific application to viruses. We quantified three cellular proteins (integrin α4β7, CD14, and CD162/PSGL-1) in the viral envelope by directly staining virion-containing cell supernatants without the requirement of additional processing steps to distinguish virus particles or specific virus purification techniques. We also show that two antigens can be simultaneously detected on the surface of individual HIV virions, probing for the tetraspanin marker, CD81, in addition to α4β7, CD14, and CD162/PSGL-1. This study demonstrates new advances in calibrated flow virometry as a tool to provide sensitive, high-throughput characterization of the viral envelope in a more efficient, quantitative manner than previously reported techniques.

Identifiants

pubmed: 33198254
pii: v12111296
doi: 10.3390/v12111296
pmc: PMC7697180
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011502
Pays : United States
Organisme : NCATS NIH HHS
ID : UG3 TR002881
Pays : United States

Références

Hum Immunol. 1987 Jan;18(1):39-52
pubmed: 3542913
J Virol. 1997 Jun;71(6):4847-51
pubmed: 9151884
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9537-9545
pubmed: 32273392
EMBO J. 1991 Apr;10(4):893-902
pubmed: 1706994
Virology. 2017 May;505:80-90
pubmed: 28235684
Cell Commun Signal. 2019 Aug 15;17(1):95
pubmed: 31416445
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7
pubmed: 8396259
Virology. 2016 Jan 15;488:20-7
pubmed: 26590794
J Infect Dis. 2000 Jul;182(1):79-87
pubmed: 10882584
mBio. 2018 Dec 11;9(6):
pubmed: 30538178
JCI Insight. 2017 Feb 23;2(4):e90626
pubmed: 28239654
J Virol. 1997 Mar;71(3):1922-30
pubmed: 9032323
Mol Cells. 2017 May 31;40(5):339-345
pubmed: 28535668
J Clin Invest. 2013 Sep;123(9):3716-27
pubmed: 23925291
Nature. 1995 Jan 12;373(6510):123-6
pubmed: 7816094
mBio. 2017 Feb 28;8(1):
pubmed: 28246356
J Virol. 2005 Jun;79(11):6577-87
pubmed: 15890896
AIDS. 1996 Dec;10(14):1611-20
pubmed: 8970680
Vaccine. 2016 Apr 29;34(20):2321-8
pubmed: 27020711
J Virol. 2020 Feb 28;94(6):
pubmed: 31852789
AIDS Res Hum Retroviruses. 1993 Nov;9(11):1157-65
pubmed: 8312057
Sci Immunol. 2017 May 12;2(11):
pubmed: 28763793
J Biol Chem. 1995 May 12;270(19):11025-8
pubmed: 7538108
Nat Microbiol. 2019 May;4(5):813-825
pubmed: 30833724
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
pubmed: 12019106
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8055-8063
pubmed: 32193343
Nature. 2002 Dec 12;420(6916):678-82
pubmed: 12478295
J Gen Virol. 1993 Jan;74 ( Pt 1):129-35
pubmed: 8093711
Immunol Today. 1998 Aug;19(8):346-51
pubmed: 9709501
Vaccine. 2016 Sep 30;34(42):5082-5089
pubmed: 27614781
Front Cell Infect Microbiol. 2017 Jan 06;6:202
pubmed: 28111619
J Virol. 1995 Jan;69(1):291-300
pubmed: 7983721
Cytometry. 1998 Oct 1;33(2):197-205
pubmed: 9773880
Curr Protoc Cytom. 2020 Sep;94(1):e79
pubmed: 32936529
J Virol. 2014 Dec;88(24):14197-206
pubmed: 25275126
PLoS Pathog. 2013;9(12):e1003852
pubmed: 24385911
J Immunol. 1984 Oct;133(4):1857-62
pubmed: 6088627
J Res Natl Inst Stand Technol. 2002 Aug 01;107(4):339-53
pubmed: 27446735
Viruses. 2015 Feb 20;7(3):857-72
pubmed: 25710889
J Virol. 2017 Jun 26;91(14):
pubmed: 28446673
AIDS. 1998;12 Suppl A:S43-52
pubmed: 9632983
J Virol. 1998 Oct;72(10):8240-51
pubmed: 9733867
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9155-61
pubmed: 27432966
PLoS Biol. 2015 Sep 16;13(9):e1002251
pubmed: 26375597
J Extracell Vesicles. 2013 Sep 12;2:
pubmed: 24223256
Sci Transl Med. 2018 Oct 3;10(461):
pubmed: 30282696
J Histochem Cytochem. 1993 Feb;41(2):265-71
pubmed: 7678271
Nature. 2002 Dec 12;420(6916):623-4
pubmed: 12478278
Clin Vaccine Immunol. 2006 Jul;13(7):715-21
pubmed: 16829607
Sci Rep. 2017 May 12;7(1):1878
pubmed: 28500324
Nature. 1995 Jan 12;373(6510):117-22
pubmed: 7529365
Sci Rep. 2019 Nov 5;9(1):16039
pubmed: 31690751
Virology. 2000 Mar 15;268(2):493-503
pubmed: 10704357
J Biol Chem. 2003 Dec 26;278(52):52347-54
pubmed: 14561735
AIDS. 2002 Jul 26;16(11):1503-9
pubmed: 12131188
J Virol. 2006 Sep;80(18):9039-52
pubmed: 16940516
Science. 1992 Dec 18;258(5090):1935-8
pubmed: 1470916
J Exp Med. 1995 Aug 1;182(2):501-9
pubmed: 7543140
Cytometry. 2001 Dec 1;45(4):250-8
pubmed: 11746094
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3704-3710
pubmed: 32029589
Retrovirology. 2014 May 29;11:41
pubmed: 24884783
Cytometry. 1998 Oct 1;33(2):166-78
pubmed: 9773877
Cytometry A. 2020 Jun;97(6):592-601
pubmed: 32476280
J Immunol. 2011 Jan 15;186(2):1044-59
pubmed: 21149598
Cytometry A. 2020 Jun;97(6):569-581
pubmed: 31250561
Viruses. 2019 Jan 20;11(1):
pubmed: 30669528
J Infect Dis. 2001 Nov 1;184(9):1127-33
pubmed: 11598835
Sci Rep. 2017 Dec 19;7(1):17769
pubmed: 29259315
J Biol Chem. 1998 Aug 7;273(32):20121-7
pubmed: 9685355
AIDS. 1992 Oct;6(10):1105-16
pubmed: 1466841
J Virol. 1987 May;61(5):1421-6
pubmed: 3033270
Cytometry A. 2012 Nov;81(11):950-9
pubmed: 22930570
Sci Rep. 2015 Sep 08;5:13875
pubmed: 26348152
Curr Pharm Des. 2010;16(33):3744-53
pubmed: 21128885
J Res Natl Inst Stand Technol. 2002 Feb 01;107(1):83-91
pubmed: 27446720
J Extracell Vesicles. 2020 Feb 3;9(1):1713526
pubmed: 32128070
J Virol. 2017 Apr 28;91(10):
pubmed: 28275191
J Virol. 2000 Apr;74(7):3264-72
pubmed: 10708443
J Virol. 2018 Jan 17;92(3):
pubmed: 29167334
Nat Med. 2014 Dec;20(12):1397-400
pubmed: 25419708
J Extracell Vesicles. 2018 Jan 21;7(1):1422674
pubmed: 29410778
Acta Virol. 1994 Feb;38(1):59-61
pubmed: 7520666
Science. 2016 Oct 14;354(6309):197-202
pubmed: 27738167
J Virol. 2007 Aug;81(15):7873-84
pubmed: 17522207
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Cytotechnology. 2013 Oct;65(5):795-802
pubmed: 23440375
Sci Rep. 2019 Dec 13;9(1):19100
pubmed: 31836798

Auteurs

Jonathan Burnie (J)

Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.
Department of Cell and Systems Biology, University of Toronto, 25 Harbord Street, Toronto, ON M5S 3G5, Canada.

Vera A Tang (VA)

Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Flow Cytometry and Virometry Core Facility, Ottawa, ON K1H 8M5, Canada.

Joshua A Welsh (JA)

Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Arvin T Persaud (AT)

Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.

Laxshaginee Thaya (L)

Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.
Department of Cell and Systems Biology, University of Toronto, 25 Harbord Street, Toronto, ON M5S 3G5, Canada.

Jennifer C Jones (JC)

Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Christina Guzzo (C)

Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.
Department of Cell and Systems Biology, University of Toronto, 25 Harbord Street, Toronto, ON M5S 3G5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH